Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study.
Acarbose
Diabetes mellitus
Muscles
Sarcopenia
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
12
07
2021
accepted:
02
09
2021
pubmed:
21
9
2021
medline:
21
9
2021
entrez:
20
9
2021
Statut:
ppublish
Résumé
Prevalence of sarcopenia has increased in patients with type 2 diabetes. The influence of glucose-lowering drugs on muscles in these patients remains unclear. We aimed to investigate the association between muscle mass/function and glucose-lowering drugs. Data of 1042 hospitalized patients with type 2 diabetes were included in this retrospective, cross-sectional study. All the patients had stable hypoglycemic therapy in the last 3 months, and performed bioelectrical impedance analysis, grip strength, and gait speed tests on admission. Skeletal muscle index [6.81 (95% CI 6.67, 6.94) vs. 7.17 (7.09, 7.24) kg/m Acarbose treatment was associated with decreased muscle mass and strength. Assessment and exercise of muscles in patients with long-term acarbose treatment should be considered.
Identifiants
pubmed: 34542866
doi: 10.1007/s13300-021-01151-6
pii: 10.1007/s13300-021-01151-6
pmc: PMC8521566
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2955-2969Subventions
Organisme : Fellowship of China Postdoctoral Science Foundation
ID : 2020M671535
Organisme : National Key R&D Program of China
ID : 2018YFC1314103
Informations de copyright
© 2021. The Author(s).
Références
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
Lancet Diabetes Endocrinol. 2014 Jan;2(1):6-7
pubmed: 24622656
J Clin Med Res. 2019 Apr;11(4):297-300
pubmed: 30937121
Diabetes Metab Syndr Obes. 2019 Jul 08;12:1057-1072
pubmed: 31372016
Clin Exp Med. 2010 Jun;10(2):139-41
pubmed: 19834782
Joint Bone Spine. 2019 May;86(3):309-314
pubmed: 30098424
ScientificWorldJournal. 2014;2014:231312
pubmed: 25580454
J Gerontol A Biol Sci Med Sci. 2014 Sep;69(9):1154-61
pubmed: 24744390
Nutrients. 2021 Jan 09;13(1):
pubmed: 33435310
Curr Diabetes Rev. 2014;10(4):231-7
pubmed: 25245021
Eur J Appl Physiol. 2010 Jan;108(1):191-5
pubmed: 19756703
Diabetol Int. 2017 Oct 20;9(2):136-142
pubmed: 30603361
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
Curr Diab Rep. 2019 Nov 27;19(12):151
pubmed: 31776781
Endokrynol Pol. 2017;68(4):482-496
pubmed: 28819951
Medicine (Baltimore). 2020 Jan;99(2):e18708
pubmed: 31914078
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830866
BMJ Open Diabetes Res Care. 2019 Sep 20;7(1):e000717
pubmed: 31641523
Diabetes Care. 2011 Nov;34(11):2381-6
pubmed: 21926282
J Nutr Health Aging. 2018;22(7):766-773
pubmed: 30080217
J Diabetes Investig. 2019 Jan;10(1):108-117
pubmed: 29660782
BMC Geriatr. 2019 Apr 29;19(1):122
pubmed: 31035928
J Diabetes Metab Disord. 2014 Aug 21;13(1):88
pubmed: 25247153
Diabetes Care. 2020 Jan;43(Suppl 1):S98-S110
pubmed: 31862752
Diabetologia. 2017 Mar;60(3):490-498
pubmed: 27904925
World J Diabetes. 2019 Mar 15;10(3):154-168
pubmed: 30891151
Sci Rep. 2016 Dec 13;6:38937
pubmed: 27958337
Diabetes Metab Res Rev. 2019 Sep;35(6):e3158
pubmed: 30908791
Diabetes Metab Syndr. 2019 May - Jun;13(3):2148-2151
pubmed: 31235149
J Clin Med. 2020 Mar 26;9(4):
pubmed: 32225082
Nutrition. 2016 Nov-Dec;32(11-12):1200-5
pubmed: 27292773
Clin Ther. 2013 Jun;35(6):880-99
pubmed: 23602502
Arch Public Health. 2014 Dec 18;72(1):45
pubmed: 25810912
Lancet Diabetes Endocrinol. 2014 Jan;2(1):46-55
pubmed: 24622668
Calcif Tissue Int. 2017 Jul;101(1):1-8
pubmed: 28246927
Nutrients. 2017 Nov 30;9(12):
pubmed: 29189738
Diabetes Metab Res Rev. 2019 May;35(4):e3126
pubmed: 30614187
J Nutr Health Aging. 2008 Aug-Sep;12(7):487-91
pubmed: 18615231
Bone. 2015 Nov;80:126-130
pubmed: 25886902
J Diabetes Complications. 2017 Jun;31(6):992-996
pubmed: 28347695